Search Results for “” – Page 5 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Change patient management Clinical outcomes

451 Publications found

Impact of Poorly Controlled Diabetes and Glycosylated Hemoglobin Values in Geriatric Hip Fracture Mortality Risk Assessment.

b

Cureus

March 1, 2023

p Diabetes

c Change patient management Clinical outcomes Observational
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial.

b

International journal of antimicrobial agents

February 1, 2023

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Cluster RCT
Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England.

b

Diabetic medicine : a journal of the British Diabetic Association

February 1, 2023

p Diabetes

c Change patient management Clinical outcomes Observational
Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis.

b

NPJ genomic medicine

January 20, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study.

b

PloS one

January 1, 2023

p COVID-19

c Change patient management Clinical outcomes Observational
Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.

b

Frontiers in pediatrics

January 1, 2023

p Newborn Screening

c Change patient management Clinical outcomes Observational
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.

b

Neuro-oncology advances

January 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

b

Neuro-oncology advances

January 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study.

b

Critical reviews in oncology/hematology

January 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.

b

Frontiers in oncology

January 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational